RevDx develops the RevDx™, a portable, 2.5kg hematology lab providing instant complete blood count (CBC) results. This user-friendly device delivers full blood analysis reports within minutes without requiring extensive preparation or specialized expertise. The technology aims to make accessible, on-the-spot blood testing available anywhere, supporting decentralized patient care.
Funding
$8M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Access to complete blood count (CBC) testing is often limited by the need for specialized, stationary lab equipment and trained personnel. This can result in delays in diagnosis and monitoring, particularly in remote locations or point-of-care settings.
Solution
EFA Technologies has developed RevDx™, a portable hematology analyzer that delivers rapid CBC results without requiring extensive training. The 2.5kg device is designed for on-site blood testing, providing a full CBC report within minutes. Its user-friendly design simplifies the testing process, eliminating the need for complex preparation or specialized expertise. The RevDx™ platform aims to improve access to crucial diagnostic information, enabling timely medical decisions in various healthcare environments.
Target Audience
The primary target audience includes healthcare providers in remote locations, point-of-care facilities, and any setting where rapid and accessible blood testing is needed.
Features
- Portable design, weighing only 2.5kg for easy transport and on-site testing
- Rapid CBC results available within minutes, eliminating waiting time
- User-friendly interface requiring no specialized training or complex preparation
- AI-powered analysis for accurate and reliable blood count results
- Multi-channel capabilities engineered into a single device